Evidence map›Paper›PMID 27648938›Full record

ArticlePLoS neglected tropical diseases2016

Molecular Diagnosis of Chagas Disease in Colombia: Parasitic Loads and Discrete Typing Units in Patients from Acute and Chronic Phases.

Carolina Hernández, Zulma Cucunubá, Carolina Flórez, Mario Olivera, Carlos Valencia, Pilar Zambrano, Cielo León, Juan David Ramírez

Erratum issuedAbstract readComparative Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Long-Term Parasitological Clearance and Cardiac Progression inTropical medicine and infectious disease · 2026
    Article
  5. Article
  6. Clinical Progression of Cardiac ChronicPathogens (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Parasite Burden ofMicroorganisms · 2024
    Article
  13. Article
  14. Frontiers in microbiology · 2024
    Article
  15. New insights intoFrontiers in immunology · 2024
    Review
  16. Article
  17. Tropical medicine and infectious disease · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Carolina HernándezRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Zulma CucunubáRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Carolina FlórezRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Mario OliveraRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Carlos ValenciaRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Pilar ZambranoGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Cielo LeónRed Chagas Colombia, Instituto Nacional de Salud, Bogotá, Colombia.
Juan David RamírezGrupo de Investigaciones Microbiológicas-UR (GIMUR), Programa de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad el Rosario, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe diagnosis of Chagas disease is complex due to the dynamics of parasitemia in the clinical phases of the disease. The molecular tests have been considered promissory because they detect the parasite in all clinical phases. Trypanosoma cruzi presents significant genetic variability and is classified into six Discrete Typing Units TcI-TcVI (DTUs) with the emergence of foreseen genotypes within TcI as TcIDom and TcI Sylvatic. The objective of this study was to determine the operating characteristics of molecular tests (conventional and Real Time PCR) for the detection of T. cruzi DNA, parasitic loads and DTUs in a large cohort of Colombian patients from acute and chronic phases. METHODOLOGY/PRINCIPAL

findingsSamples were obtained from 708 patients in all clinical phases. Standard diagnosis (direct and serological tests) and molecular tests (conventional PCR and quantitative PCR) targeting the nuclear satellite DNA region. The genotyping was performed by PCR using the intergenic region of the mini-exon gene, the 24Sa, 18S and A10 regions. The operating capabilities showed that performance of qPCR was higher compared to cPCR. Likewise, the performance of qPCR was significantly higher in acute phase compared with chronic phase. The median parasitic loads detected were 4.69 and 1.33 parasite equivalents/mL for acute and chronic phases. The main DTU identified was TcI (74.2%). TcIDom genotype was significantly more frequent in chronic phase compared to acute phase (82.1% vs 16.6%). The median parasitic load for TcIDom was significantly higher compared with TcI Sylvatic in chronic phase (2.58 vs.0.75 parasite equivalents/ml). CONCLUSIONS/SIGNIFICANCE: The molecular tests are a precise tool to complement the standard diagnosis of Chagas disease, specifically in acute phase showing high discriminative power. However, it is necessary to improve the sensitivity of molecular tests in chronic phase. The frequency and parasitemia of TcIDom genotype in chronic patients highlight its possible relationship to the chronicity of the disease.

Indexed as

Parasite LoadAcute DiseaseAdultChagas DiseaseChronic DiseaseColombiaDNA, ProtozoanExonsFemaleGenetic VariationGenotypeHumansMaleMiddle AgedMolecular TypingReal-Time Polymerase Chain ReactionDNA, Protozoan

Identifiers

PMID27648938
PMCPMC5029947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.